6.6068

14.79% -1.1232

Polyrizon Ltd (PLRZ)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$7.73

Offen:

$7.37

24-Stunden-Volumen:

75,442

Relative Volume:

0.03

Marktkapitalisierung:

$6.92M

Einnahmen:

Nettoeinkommen (Verlust:

$-1.13M

KGV:

-0.1156

EPS:

-57.1626

Netto-Cashflow:

$-2.63M

1W Leistung:

-41.14%

1M Leistung:

+72.64%

6M Leistung:

+59.59%

1J Leistung:

-99.73%

1-Tages-Spanne:

$6.39

$7.37

1-Wochen-Bereich:

$6.39

$11.26

52-Wochen-Spanne:

$2.88

$4,200.00

Polyrizon Ltd Stock (PLRZ) Company Profile

Firmenname

Polyrizon Ltd

Sektor

Healthcare (1135)

Branche

Biotechnology (634)

Telefon

Adresse

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

PLRZ's Discussions on Twitter

Vergleichen Sie PLRZ mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PLRZ Polyrizon Ltd	6.6471	8.05M	0	-1.13M	-2.63M	-57.16
VRTX Vertex Pharmaceuticals Inc	460.39	116.79B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	787.44	81.91B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	398.97	53.87B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	848.40	52.46B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	176.79	37.48B	447.02M	-1.18B	-906.14M	-6.1812

Polyrizon Ltd Aktie (PLRZ) Neueste Nachrichten

Dec 20, 2025

What risks investors should watch in Polyrizon Ltd. stockWeekly Trade Report & Free Weekly Watchlist of Top Performers - Улправда

Dec 20, 2025

Dec 19, 2025

Aug Drivers: What risks investors should watch in Polyrizon Ltd. stock2025 Growth vs Value & Capital Protection Trade Alerts - Улправда

Dec 19, 2025

Polyrizon submits pre-request for designation to FDA for PL-16 viral blocker - marketscreener.com

Dec 19, 2025

Polyrizon Files FDA Pre-Request for Designation of PL-16 Intranasal Viral Blocker - TipRanks

Dec 19, 2025

Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses - The Manila Times

Dec 19, 2025

Polyrizon Submits Pre-Request for Designation to FDA - One News Page

Dec 19, 2025

Is Polyrizon Ltd. stock undervalued vs historical averagesEarnings Growth Summary & Real-Time Market Sentiment Alerts - bolumsonucanavari.com

Dec 19, 2025

Dec 14, 2025

Winners Losers: Can Polyrizon Ltd stock attract ESG capital inflows2025 AllTime Highs & Breakout Confirmation Trade Signals - moha.gov.vn

Dec 14, 2025

Dec 13, 2025

Top Medical Stocks To Keep An Eye OnDecember 2nd - MarketBeat

Dec 13, 2025

Polyrizon unveils promising results for intranasal naloxone hydrogel - MSN

Dec 13, 2025

Resistance Check: Is Polyrizon Ltd stock a buy on dipsShort Setup & Safe Entry Point Identification - moha.gov.vn

Dec 13, 2025

Dec 12, 2025

Polyrizon completes FDA pre-submission meeting for PL-14 nasal spray - MSN

Dec 12, 2025

Dec 11, 2025

Polyrizon’s naloxone hydrogel shows positive permeation kinetics - TipRanks

Dec 11, 2025

Polyrizon’s intranasal naloxone hydrogel shows promising test results - Investing.com

Dec 11, 2025

Polyrizon Unveils Promising Results for Intranasal Naloxone Hydrogel - TipRanks

Dec 11, 2025

Polyrizon’s intranasal naloxone hydrogel shows promising test results By Investing.com - Investing.com Canada

Dec 11, 2025

Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal Naloxone Hydrogel Program - The Manila Times

Dec 11, 2025

[6-K] Polyrizon Ltd. Current Report (Foreign Issuer) | PLRZ SEC FilingForm 6-K - Stock Titan

Dec 11, 2025

Polyrizon Announces Promising Permeation Kinetics Supporting Advancement of Its Intranasal ... - Enidnews.com

Dec 11, 2025

Polyrizon (Nasdaq: PLRZ) shows rapid permeation in intranasal naloxone hydrogel preclinical studies - Stock Titan

Dec 11, 2025

Dec 10, 2025

Polyrizon Ltd trading halted, news pending - MSN

Dec 10, 2025

Dec 09, 2025

Earnings Update: Is Polyrizon Ltd stock a buy on dipsJuly 2025 Action & Real-Time Stock Price Movement Reports - BỘ NỘI VỤ

Dec 09, 2025

Dec 08, 2025